[1]
Petukhov, A. , Tursymbek, S. and Barlev, N. 2025. NKG2DL as a promising targets for colorectal cancer immunotherapy. Eurasian Journal of Applied Biotechnology. 3s (Nov. 2025). DOI:https://doi.org/10.11134/btp.3s.2025.35.